ARYWX | MGLIX | ARYWX / MGLIX | |
Total Expense Ratio | 1.62 | 0.94 | 172% |
Annual Report Gross Expense Ratio | 1.62 | 0.95 | 171% |
Fund Existence | 14 years | 16 years | - |
Gain YTD | 3.488 | 3.616 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 858M | 2.22B | 39% |
Annual Yield % from dividends | 1.58 | 2.51 | 63% |
Returns for 1 year | 7.36 | 2.42 | 305% |
Returns for 3 years | 12.29 | -3.43 | -359% |
Returns for 5 years | 25.29 | 15.01 | 168% |
Returns for 10 years | 43.79 | 32.21 | 136% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMVX | 18.42 | 0.15 | +0.82% |
Voya Mid Cap Research Enhanced Index R | |||
OPTFX | 90.47 | 0.55 | +0.61% |
Invesco Discovery Large Cap A | |||
MUIGX | 17.56 | 0.07 | +0.40% |
Nationwide BNY Mellon Dyn US Core R6 | |||
GCVRX | 24.29 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts R | |||
LHCTX | 18.56 | 0.05 | +0.27% |
Lord Abbett Health Care R5 |